Raykov Rosty 4
4 · FENNEC PHARMACEUTICALS INC. · Filed Oct 8, 2025
Insider Transaction Report
Form 4
Raykov Rosty
Director
Transactions
- Exercise/Conversion
Common shares
2025-10-08$2.45/sh+4,609$11,292→ 87,110 total - Exercise/Conversion
Stock Options
2025-10-08$2.45/sh−4,609$11,292→ 1,634,184 totalExercise: $2.45From: 2016-07-05Exp: 2026-07-05→ options (4,609 underlying)
Footnotes (1)
- [F1]Shares acquired through the exercise of an option contract with strike price of $2.45 and an expiration date of July 5, 2026.